The use of a surrogate endpoint in a clinical trial may allow faster approval of a novel treatment, but at the cost of increased uncertainty about treatment benefit.
This paper presents a framework for surrogate endpoint evaluation
bit.ly/4daxpUf
bmj.com
Recommendations for evaluating a single surrogate endpoint (REASSurE): consensus based, surrogate evaluation framework with explanation and elaboration